Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 1,961,795 | 1,961,795 | 0 | $367.40M | $402.68M | 24.64% | +$35.27M |
| Liquidia Corporation(LQDA) | 8,118,892 | 8,118,892 | 0 | $647.32M | $245.68M | 15.03% | -$401.64M |
| ABIVAX Société AnonymeADS(ABVX) | 1,557,924 | 1,557,924 | 0 | $207.61M | $154.27M | 9.44% | -$53.34M |
| Vaxcyte, Inc.(PCVX) | 2,188,636 | 2,188,636 | 0 | $127.23M | $124.53M | 7.62% | -$2.69M |
| Exelixis, Inc.(EXEL) | 1,553,262 | 1,553,262 | 0 | $84.51M | $90.73M | 5.55% | +$6.21M |
| Tango Therapeutics, Inc.(TNGX) | 2,500,103 | 2,501,246 | +1,143 | $78.15M | $62.41M | 3.82% | -$15.75M |
| Adma Biologics Inc | 5,725,007 | 5,875,007 | +150,000 | $47.92M | $58.93M | 3.61% | +$11.01M |
| Immunocore Holdings plcADS(IMCR) | 1,381,317 | 1,672,141 | +290,824 | $43.86M | $50.65M | 3.10% | +$6.79M |
| Avalo Therapeutics, Inc.(AVTX) | 3,163,866 | 3,268,303 | +104,437 | $58.47M | $50.10M | 3.07% | -$8.37M |
| LB Pharmaceuticals Inc(LBRX) | 1,438,070 | 1,509,621 | +71,551 | $46.67M | $49.62M | 3.04% | +$2.95M |
| Viridian Therapeutics, Inc.(VRDN) | 2,193,981 | 2,193,981 | 0 | $40.30M | $45.17M | 2.76% | +$4.87M |
| Vor Biopharma Inc.(VOR) | 1,925,066 | 1,925,066 | 0 | $35.44M | $36.73M | 2.25% | +$1.29M |
| Inventiva S.A.ADS(IVA) | 8,163,191 | 9,185,935 | +1,022,744 | $30.86M | $33.90M | 2.07% | +$3.04M |
| Opus Genetics, Inc.(IRD) | 6,077,084 | 5,960,972 | -116,112 | $24.98M | $28.85M | 1.77% | +$3.87M |
| Aura Biosciences, Inc.(AURA) | 4,298,248 | 4,590,253 | +292,005 | $30.52M | $28.83M | 1.76% | -$1.69M |
| Anika Therapeutics Inc | 1,435,130 | 1,435,130 | 0 | $21.00M | $28.21M | 1.73% | +$7.22M |
| SAB Biotherapeutics, Inc.(SABS) | 7,967,207 | 8,736,898 | +769,691 | $31.07M | $27.70M | 1.69% | -$3.38M |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 2,500,000 | 2,794,484 | +294,484 | $19.32M | $27.61M | 1.69% | +$8.28M |
| Faeth Therapeutics, Inc.(FTH) | 629,467 | 890,210 | +260,743 | $15.74M | $26.47M | 1.62% | +$10.74M |
| Tyra Biosciences, Inc.(TYRA) | 806,986 | 910,749 | +103,763 | $25.78M | $19.92M | 1.22% | -$5.86M |
| Obsidian Therapeutics Inc | 0 | 886,281 | +886,281 | $0 | $12.17M | 0.74% | +$12.17M |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 0 | 1,163,010 | +1,163,010 | $0 | $10.58M | 0.65% | +$10.58M |
| Artiva Biotherapeutics, Inc.(ARTV) | 1,736,111 | 1,481,043 | -255,068 | $16.84M | $10.55M | 0.65% | -$6.30M |
| Verrica Pharmaceuticals Inc.(VRCA) | 923,910 | 923,910 | 0 | $5.65M | $4.43M | 0.27% | -$1.22M |
| Tcgx Acquisition CorpCL A | 0 | 200,000 | +200,000 | $0 | $2.50M | 0.15% | +$2.50M |
| Cellectar Biosciences, Inc.(CLRB) | 469,998 | 469,998 | 0 | $1.31M | $864.8K | 0.05% | -$441.8K |
| MBX Biosciences, Inc.(MBX) | 200,000 | 0 | -200,000 | $11.04M | $0 | — | -$11.04M |
| Xenon Pharmaceuticals Inc.(XENE) | 889,944 | 0 | -889,944 | $53.72M | $0 | — | -$53.72M |